Dopamina o norepinefrina en el shock séptico

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0907118

N Engl J Med 2010; 362:779-89

"Conclusions: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events. (ClinicalTrials.gov number, NCT00314704.)"